ZENALPHA SOLUTION

Pajjiż: Kanada

Lingwa: Ingliż

Sors: Health Canada

Ingredjent attiv:

VATINOXAN HYDROCHLORIDE; MEDETOMIDINE HYDROCHLORIDE

Disponibbli minn:

DECHRA VETERINARY PRODUCTS INC.

Dożaġġ:

10MG; 0.5MG

Għamla farmaċewtika:

SOLUTION

Kompożizzjoni:

VATINOXAN HYDROCHLORIDE 10MG; MEDETOMIDINE HYDROCHLORIDE 0.5MG

Rotta amministrattiva:

INTRAMUSCULAR

Unitajiet fil-pakkett:

100

Tip ta 'preskrizzjoni:

Prescription Recommended

Grupp terapewtiku:

DOGS

Sommarju tal-prodott:

Active ingredient group (AIG) number: 0264621001

L-istatus ta 'awtorizzazzjoni:

APPROVED

Data ta 'l-awtorizzazzjoni:

2023-05-01

Fuljett ta 'informazzjoni

Dechra March 20, 2023
Zenalpha – label
Sterile / Stérile
DIN xxxxxxxx
Veterinary Use Only / Usage vétérinaire seulement
Zenalpha
Medetomidine hydrochloride and Vatinoxan hydrochloride Injection /
Chlorhydrate de médétomidine et chlorhydrate de vatinoxan pour
injection
0.5 mg/mL & 10 mg/mL
10 mL
Sedative and analgesic for intramuscular administration in dogs only.
See package insert for complete information.
Sédatif et analgésique pour administration intramusculaire chez les
chiens seulement.
Voir la notice pour les informations complètes.
Dechra Veterinary Products Inc.
Lot :
Exp.:
Dechra March 20, 2023
Zenalpha – carton – front panel
Sterile / Stérile
DIN xxxxxxxx
Veterinary Use Only / Usage vétérinaire seulement
Zenalpha
Medetomidine hydrochloride and Vatinoxan hydrochloride Injection /
Chlorhydrate de médétomidine et chlorhydrate de vatinoxan pour
injection
WARNINGS: Keep out of reach of children. Consult package insert for
complete warnings.
MISES EN GARDE: Garder hors de la portée des enfants. Se référer à
la notice pour les mises en garde
complètes.
10 mL
Zenalpha – carton – side panel - English
ACTIVE INGREDIENTS: Each mL contains 0.5 mg medetomidine hydrochloride
and 10 mg vatinoxan
hydrochloride.
PRESERVATIVES: Methylparaben 1.8 mg/mL and propylparaben 0.2 mg/mL.
INDICATIONS: Zenalpha is indicated for use as a sedative and analgesic
to facilitate clinical
examinations, clinical procedures, and minor surgical procedures in
dogs only.
DOSAGE AND ADMINISTRATION: Zenalpha is administered at 1 mg/m
2
medetomidine and 20 mg/m
2
vatinoxan intramuscularly. Calculate the dose using 1 mg
medetomidine/m
2
body surface area or use
the dosing table in the package insert. Administer by intramuscular
injection.
See package insert for complete information.
STORAGE: Store between 15 and 25
o
C in its carton to protect from light. Do not freeze. Discard any
unused portion 3 months after first opening.
Zenalpha – carton – side panel - French
INGRÉDIENTS ACTIFS: Chaque ml renferme 0,5 mg de